Doxycycline Slashes Infection Risk for C. diff-prone Pneumonia Patients
A new VA study finds a 45% reduction in Clostridioides difficile infections among high-risk patients with the use of doxycycline instead of azithromycin.
Category: Pneumonia
Pneumonia
Latest
Pneumonia
Latest
Innoviva’s Bacterial Pneumonia Treatment Secures FDA Approval
Xacduro was approved for intravenous use in patients 18 years of age and older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.
Pneumonia
Latest
High-dose Influenza Vaccines May Reduce Mortality, Hospitalization
High-dose influenza vaccines in older adults reduced mortality risk by 49% and reduced hospitalization for influenza or pneumonia by 64% compared with standard-dose vaccination.
Bactiguard’s Endotracheal Tube Reduced Ventilator-associated Pneumonia
A study published in the Annals of Intensive Care shows a 53% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube.
Read More
Pfizer COVID-19 and Pneumococcal Vaccines Safe to Co-administer
Pfizer’s Prevnar 20 pneumococcal vaccine can be safely co-administered with the Pfizer-BioNTech COVID-19 vaccine, according to a Phase 3 study.
Read More
Merck VaxNeuvance Pneumococcal Vaccine Approved in EU
The European Commission approved Merck’s VaxNeuvance (Pneumococcal 15-valent Conjugate Vaccine) for prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in individuals 18 years of age and older.
Read More
New Potential Drug Target for Pneumonia
Researchers in Sweden report that a recently discovered inflammatory mediator appears to have an important role in pneumonia and contribute to the killing of bacteria.
Read More
Disseminated Coccidioidomycosis Mimics Lung Cancer
A case study presented at Chest 2021 reports that the fungal infection coccidioidomycosis may have varied clinical presentations, including mimicking lung cancer.
Read More
Antibiotic Overuse Likely in Patients with Severe COVID-19 Pneumonia
Only 21% of patients with severe pneumonia caused by SARS-CoV-2 have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics.
Read More
FDA Approves Prevnar 20 Pneumoccocal Vaccine
The US FDA has approved Pfizer’s Prevnar 20 Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia in adults age 18 and older.
Read More
New Clinical Practice Guideline on Community-Acquired Pneumonia
The American Thoracic Society released a new clinical practice guideline on community-acquired pneumonia.
Read More
Study: History of Pneumonia Leads to Worse Covid-19 Outcomes
A history of pneumonia is the second-greatest overall risk factor for death from COVID-19, Harvard University researchers said.
Read More
COVID-19 Pneumonia versus ‘Typical’ Pneumonia
COVID-19 pneumonia differs from non-COVID-19 pneumonia in the way that it colonizes areas of the lungs.
Read More
Ventilator-associated Pneumonia Incidence in COVID-19 Patients
COVID-19 has forced many severely ill patients to undergo mechanical ventilation for extended durations, an intervention that can increase their risks of other hospital-acquired infections such as ventilator-associated pneumonia (VAP).
Read More
Spreading Light, and Awareness, on World Pneumonia Day
A total of 232 buildings and monuments from 48 different countries will be illuminated in blue between 9:00 p/m and 10:00 p/m on November 12 in recognition of World Pneumonia Day.
Read More